Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis.
about
Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosisModifier genes and variation in cystic fibrosisNitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy.Cystic fibrosis lung disease: the role of nitric oxide.Yet another role for the cystic fibrosis transmembrane conductance regulator.Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.Endosomal hyperacidification in cystic fibrosis is due to defective nitric oxide-cylic GMP signalling cascadeReduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.Exhaled nitric oxide is decreased by exposure to the hyperbaric oxygen therapy environment.Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide.Increased carbon monoxide in exhaled air of patients with cystic fibrosis.Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis.An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.Inflammatory markers: exhaled nitric oxide and carbon monoxide during the ovarian cycleInducible NO synthase expression is low in airway epithelium from young children with cystic fibrosisAbrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airwaysWhat have we learned from mouse models for cystic fibrosis?cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cellsImpaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.Antibiotic and anti-inflammatory therapies for cystic fibrosis.Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.Assessment and monitoring of cystic fibrosis lung disease in infants and young children.Update on exhaled nitric oxide in pulmonary disease.Cystic fibrosis CFBE41o- cells contain TLR1 SNP I602S and fail to respond to Mycobacterium abscessusRole of catalase in Campylobacter jejuni intracellular survivalEffects of nitric oxide on Pseudomonas aeruginosa infection of epithelial cells from a human respiratory cell line derived from a patient with cystic fibrosisPharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium.Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium.Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.Regulation of anion secretion by nitric oxide in human airway epithelial cells.Myeloperoxidase and protein oxidation in cystic fibrosis.Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells.Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression.Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis.Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C.
P2860
Q24548775-C5AC737E-09E1-4D40-99FC-DE7687C2A7CBQ28362881-FBB055B6-3D97-49EE-B3FE-29412962627EQ30308607-3E69567A-FD4B-432C-8259-A27CAB0BE4F2Q33787847-FE96BFBE-9108-49F2-80D1-BED165A57874Q33806101-44DF521B-7F02-4478-A739-FFB7061647BCQ33958399-0F65F224-50FB-4786-A52E-D6EE1A6130BFQ34683157-F08DDC77-D358-4148-97A8-54E1AAA2EDC1Q35043722-703915E9-3E82-4ECD-9110-3B36AE0AB14CQ35055371-E834BC7D-025A-41B2-BDE6-5C368D21B01BQ35161457-F3F468C0-68AB-43EB-9114-992642BF5E7CQ35524948-4D154ABD-0A97-4195-B2C8-9D4811E88563Q35532597-25537F6B-45D9-4BFF-BAF8-920E880A6B07Q35532841-09074081-A853-4AE3-B091-01F1AB2035CBQ35533642-19D6EFC9-78DD-4FE2-810F-6BFE086D6AE5Q35534747-4A8A5740-03F5-4B81-9234-AE8D078D177CQ35537039-40E0A293-CE70-4B50-83B0-6B4B174D954AQ35859118-49841B43-BC5E-45F3-B7A7-E37B008F7F38Q36203136-EC98F4E4-B9B5-4FC9-BBD7-4980192A50D0Q36675994-7C88B9D5-A62B-46F2-B41E-86E18077DB29Q36874346-9115A469-9015-4264-8F37-70DCB4844186Q36977348-A0F60EA5-C631-4029-A290-A715BC639FC1Q37037086-C351ADED-6B8F-470D-A1D6-055825F67328Q37201467-B8C79058-DFC1-4C77-BDFD-873D46F51D96Q37387553-5F2FB92B-2BC5-4EA7-AE55-65988A284F08Q37754879-8711575A-CAE1-4E5F-BA69-0D8C950B1CD5Q37979252-AEE93B7D-1416-45EB-A7F2-854B23C55767Q39195696-904FCCAB-D6FB-4D8E-948A-631EE23EC11EQ39516878-23C6FBC1-B4BD-4240-8931-75549C3DD95BQ39746027-F048B637-CB83-4B58-81B2-966D5AF6A039Q40116337-25B31772-E40C-42C0-B7B6-BF9730E0F530Q40431922-C95CB0A0-5074-44D5-BD7B-E26BF43D9040Q40563302-FD6AE157-ADCA-48A0-A32E-C7755C2EC7C1Q40639006-AA06D3F6-00EF-4EA4-B79E-9570D4DA94A3Q40795328-723EAB27-2906-41B9-817D-C5E887D5FED3Q40859174-8AB96A8B-C557-4BC1-B00C-B86D35051E9EQ40902516-CF80CD7B-A1E2-49E7-A875-3813FBAC4FB8Q40909336-018A851C-7480-4D2C-AC61-69C1F8B87853Q42421460-987F6040-00F3-406A-B6BF-13E982E65958Q42513496-C211008F-57C5-44A0-A8F2-67A8926E0369Q44980713-46F66F7F-43B8-455B-88AF-B91F20826AD0
P2860
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Lack of inducible nitric oxide ...... infection in cystic fibrosis.
@en
Lack of inducible nitric oxide ...... infection in cystic fibrosis.
@nl
type
label
Lack of inducible nitric oxide ...... infection in cystic fibrosis.
@en
Lack of inducible nitric oxide ...... infection in cystic fibrosis.
@nl
prefLabel
Lack of inducible nitric oxide ...... infection in cystic fibrosis.
@en
Lack of inducible nitric oxide ...... infection in cystic fibrosis.
@nl
P2093
P2860
P1476
Lack of inducible nitric oxide ...... infection in cystic fibrosis.
@en
P2093
Gruenert DC
Springall DR
P2860
P304
P356
10.1002/(SICI)1096-9896(199803)184:3<323::AID-PATH2>3.0.CO;2-2
P577
1998-03-01T00:00:00Z